Dynocardia is a biomedical device development company structured around addressing critical unmet needs to improve healthcare. The firm's lead diagnostic device - ViTrackĀ - is powered by the firm's proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. In contrast to conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. With data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, the firm's defeloped device enables early intervention prior to acute events. Originally located in Lowell MA (at time of application/award) the firm appears to have relocated to the Cambridge MA innovation Center,
